VERTEX PHARMACEUTICALS INC / MA ($VRTX)
Filing Information
| Accession Number | 0000875320-26-000022 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 26, 2026 |
| Document Date | Jan 22, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
6,800
Total Value
$0.00
P&L
+inf% (+$3,087,200.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer | Common Stock | โ | Jan 22, 2026 | Grant/Award | 4,720 | $0.00 | $0.00 | 20,858 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Jan 22, 2026 | Grant/Award | 2,080 | $0.00 | $0.00 | 22,938 | Direct | โ | View Details |